Sea4Us is a biopharmaceutical company focused on the discovery and development of new pharmaceutical drugs based on novel marine compounds for unmet clinical needs.
Sea4Us’s core activities are based on compound library generation, drug discovery and preclinical development. Our compound library derives from unique marine organisms, which are important sources of ion channel modulators. We screen such compounds against a number of molecular targets (ion channels) as NaV, KV, CaV and TRP channels. Such experimental screening is complemented by computational in silico analysis that tune the development of innovative molecules.
Due to its nature, the Sea4Us’s Drug Discovery & Development Platform allows the discovery of novel pharmaceutical drugs for several unmet clinical needs. It can be used to identify novel modulators for ion channels involved in different pathologies such as chronic pain, epilepsy, diabetes, cardiac arrhythmia, hypertension, and skin diseases, among others.